Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on June 13, 2025
God Is Good All Ways and Always: A Memoir of Faith, Healing, and Hope
EIN Presswire
·
June 13, 2025
In God is Good All Ways and Always, Donna Watson shares how faith turned pain into healing—offering hope and strength for those facing life’s hardest seasons. TRENTON, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- In her heart-moving debut …
CareGivers of America Announces New Location
EIN Presswire
·
June 13, 2025
CareGivers of America opens a new Margate location, boosting access to high-quality home care services for families across Broward County. MARGATE, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- CareGivers of America, a recognized and trusted …
NutriSelect and The Center for Applied Health Sciences Partner to Advance AI-Driven Personalized Supplement Science
EIN Presswire
·
June 13, 2025
Strategic collaboration aims to validate NutriSelect's AI supplement engine through clinical trials and biomarker-based performance optimization. CLEARWATER, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- NutriSelect, the visionary AI-powered …
THE FLORIDA ASSOCIATION OF HEALTHY START COALITIONS LAUNCHES NEW BRANDING AND WEBSITE
EIN Presswire
·
June 13, 2025
TALLAHASSEE, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- The Florida Association of Healthy Start Coalitions (FAHSC) is excited to announce their rebranding with a new logo and website. Harnessing the power of over 30 years as a leading …
Vaxart Announces Preliminary Results of Annual Meeting of Stockholders
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
LEXINGTON, Mass., June 13, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
GlobeNewswire
·
June 13, 2025
TTAM Commits to Comply with Company’s Privacy Policy and All Applicable Laws TTAM Commits to Adopting Additional Consumer Protections and Privacy Safeguards to Enhance Protections for Customer Data and Privacy No Changes to 23andMe’s Privacy Policy or …
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier in …
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies
GlobeNewswire
·
June 13, 2025
RIYADH, Saudi Arabia, June 13, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital …
'Let It Out' Book Offers Breakthrough Approach to Emotional Healing and Connection
EIN Presswire
·
June 13, 2025
Powerful pathways to reclaim your emotional voice and deepen human connections HOLLYWOOD, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- A revolutionary new book by PAIRS Foundation CEO Seth Eisenberg is breaking the silence around emotional …
Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing
GlobeNewswire
·
June 13, 2025
St. Paul, MN, June 13, 2025 (GLOBE NEWSWIRE) -- With federal cost-cutting and deregulation reshaping workplace safety oversight, the responsibility to protect workers from extreme heat is falling squarely on employers. While OSHA’s National Emphasis …
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
GlobeNewswire
·
June 13, 2025
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to …
The Dental Medical Convergence Announces Featured Article and Podcast Interview on KevinMD Highlighting Dangers of Dental Infections
GlobeNewswire
·
June 13, 2025
Eustis, Florida , June 13, 2025 (GLOBE NEWSWIRE) -- The Dental Medical Convergence, a nonprofit dedicated to educating the public about the link between oral health and systemic disease, announced today that KevinMD—widely recognized as social media’s …
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
GlobeNewswire
·
June 13, 2025
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
GlobeNewswire
·
June 13, 2025
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and 1001240330 Ontario Inc. (“Subco”), a wholly-owned …
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
GlobeNewswire
·
June 13, 2025
– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma – – Data supports ongoing Phase 2 …
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
GlobeNewswire
·
June 13, 2025
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device …
GT Biopharma Appoints New Member to its Board of Directors
GlobeNewswire
·
June 13, 2025
SAN FRANCISCO, CALIFORNIA, June 13, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer …
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
GlobeNewswire
·
June 13, 2025
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for …
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
GlobeNewswire
·
June 13, 2025
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that leading independent proxy …